Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: Clinical efficacy and bacterial viability data

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 8, 2015, Pages 1011-1018

  Costello, S P ^a,b,d   Conlon, M A ^c   Vuaran, M S ^c   Roberts Thomson, I C ^b,d   Andrews, J M ^a,d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL;

AEROBE; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL COUNT; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIABILITY; BIFIDOBACTERIUM; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; COLIFORM BACTERIUM; CONTROLLED STUDY; ESCHERICHIA COLI; FECAL MICROBIOTA TRANSPLANT; FECES MICROFLORA; FROZEN STOOL; HUMAN; LACTOBACILLUS; LOW TEMPERATURE PROCEDURES; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT INFECTION; ADULT; AGED; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; FREEZING; LABORATORY DIAGNOSIS; MALE; MICROBIAL VIABILITY; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; PROCEDURES; RECURRENT DISEASE; RETROSPECTIVE STUDY; SECONDARY PREVENTION; TREATMENT OUTCOME;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; FREEZING; HUMANS; MALE; MICROBIAL VIABILITY; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; SPECIMEN HANDLING; TREATMENT OUTCOME;

EID: 84941733300     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13366     Document Type: Article

References (32)

1. Lessa FC, Mu Y, Bamberg WM, et al., Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372: 825-34.
2. Magill SS, Edwards JR, Bamberg W, et al., Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014; 370: 1198-208.
3. Wilson R, Beerbaum P, Giglio S,. Community and hospital acquired Clostridium difficile in South Australia-ribotyping of isolates and a comparison of laboratory detection methods. Lett Appl Microbiol 2015; 60: 33-6.
4. Hopkins MJ, Macfarlane GT,. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002; 51: 448-54.
5. Goldberg E, Amir I, Zafran M, et al., The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species. Eur J Clin Microbiol Infect Dis 2014; 33: 377-83.
6. Lawley TD, Clare S, Walker AW, et al., Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8: e1002995.
7. Loo VG, Poirier L, Miller MA, et al., A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-9.
8. McDonald LC, Killgore GE, Thompson A, et al., An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-41.
9. Oleastro M, Coelho M, Giao M, et al., Outbreak of Clostridium difficile PCR ribotype 027-the recent experience of a regional hospital. BMC Infect Dis 2014; 14: 209.
10. Honda H, Dubberke ER,. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol 2014; 30: 54-62.
11. van Nood E, Vrieze A, Nieuwdorp M, et al., Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-15.
12. Starkey JM, MacPherson JL, Bolgiano DC, Simon ER, Zuck TF, Sayers MH,. Markers for transfusion-transmitted disease in different groups of blood donors. JAMA 1989; 262: 3452-4.
13. Gough E, Shaikh H, Manges AR,. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
14. Gerding DN, Meyer T, Lee C, et al., Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 2015; 313: 1719-27.
15. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A,. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761-7.
16. Satokari R, Mattila E, Kainulainen V, Arkkila PE,. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection-an observational cohort study. Aliment Pharmacol Ther 2015; 41: 46-53.
17. Youngster I, Sauk J, Pindar C, et al., Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58: 1515-22.
18. Bakken JS, Borody T, Brandt LJ, et al., Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-9.
19. Luo C, Walk ST, Gordon DM, Feldgarden M, Tiedje JM, Konstantinidis KT,. Genome sequencing of environmental Escherichia coli expands understanding of the ecology and speciation of the model bacterial species. Proc Natl Acad Sci USA 2011; 108: 7200-5.
20. Allen SJ, Wareham K, Wang D, et al., Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2013; 382: 1249-57.
21. Tojo R, Suarez A, Clemente MG, et al., Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014; 20: 15163-76.
22. Costello SP, Chung A, Andrews JM, Fraser RJ,. Fecal Microbiota Transplant for Clostridium difficile Colitis-Induced Toxic Megacolon. Am J Gastroenterol 2015; 110: 775-7.
23. Mattila E, Uusitalo-Seppala R, Wuorela M, et al., Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-6.
24. Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ,. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013; 4: 125-35.
25. Waite DW, Deines P, Taylor MW,. Quantifying the impact of storage procedures for faecal bacteriotherapy in the critically endangered New Zealand parrot, the kakapo (Strigops habroptilus). Zoo Biol 2013; 32: 620-5.
26. Acha SJ, Kuhn I, Mbazima G, Colque-Navarro P, Mollby R,. Changes of viability and composition of the Escherichia coli flora in faecal samples during long time storage. J Microbiol Methods 2005; 63: 229-38.
27. Bonten MJ, Nathan C, Weinstein RA,. Recovery of nosocomial fecal flora from frozen stool specimens and rectal swabs: comparison of preservatives for epidemiological studies. Diagn Microbiol Infect Dis 1997; 27: 103-6.
28. Keith SC Jr,. Factors influencing the survival of bacteria at temperatures in the vicinity of the freezing point of water. Science 1913; 37: 877-9.
29. Dan M, Richardson J, Miliotis MD, Koornhof HJ,. Comparison of preservation media and freezing conditions for storage of specimens of faeces. J Med Microbiol 1989; 28: 151-4.
30. Wasfy M, Oyofo B, Elgindy A, Churilla A,. Comparison of preservation media for storage of stool samples. J Clin Microbiol 1995; 33: 2176-8.
31. O'Brien KL, Bronsdon MA, Dagan R, et al., Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 2001; 39: 1021-4.
32. Haines RB,. The effect of freezing on bacteria. Proc R Soc Lond B Biol Sci 1938; 124: 451-63.